We’re getting excited for AACR IO 2026 in Los Angeles (Feb 18–21)! Bhardwaj Lab members will be giving talks and presenting posters. Please come find us there to chat about dendritic cells, immunotherapy, and cancer vaccines. @theaacr.bsky.social www.aacr.org/meeting/aacr...

Preprint: Targeting Neoantigens Conserved Across Organs and Species Overcomes Tumor Immune Escape @bhardwajlab.bsky.social @sinaiimmuno.bsky.social papers.ssrn.com/sol3/papers....

The inaugural AACR IO Conference on Discovery and Innovation in Cancer Immunology takes place February 23-26 in Los Angeles. Learn why Dr. Antoni Ribas says #AACRIO25 is “the must-attend immuno-oncology event of the year."  www.aacr.org/about-the-aa...  #AACRStories

Excited to share our review "Pipe dream to Pipeline: Journey of cancer vaccines and the road ahead" that is now published in Cell Reports Medicine by Cell Press! (1/4)

Antigen presentation requirements for effective cDC1-based cancer immunotherapy https://www.biorxiv.org/content/10.64898/2026.01.24.701412v1

Submit a clinical trial or late-breaking abstract by January 20 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more: buff.ly/bb9lwPV #AACRIO26

New year, new Bluesky account! We’re the Bhardwaj Lab at @mountsinainyc.bsky.social studying cancer immunology and immunotherapy. Here’s a snapshot of some of our team from our New Year kickoff party. Looking forward to connecting and sharing papers, preprints and lab updates.